丙戊酸在肝病患者中的处置情况。 - Suppr

Suppr

超能文献

Disposition of valproic acid in patients with liver disease.

作者信息

Klotz U, Rapp T, Müller W A

出版信息

Eur J Clin Pharmacol. 1978 Mar 17;13(1):55-60. doi: 10.1007/BF00606683.

DOI:10.1007/BF00606683

PMID:346355

Abstract

摘要

相似文献

Disposition of valproic acid in patients with liver disease.丙戊酸在肝病患者中的处置情况。

Eur J Clin Pharmacol. 1978 Mar 17;13(1):55-60. doi: 10.1007/BF00606683.

Pharmacokinetics and bioavailability of sodium valproate.丙戊酸钠的药代动力学和生物利用度。

Clin Pharmacol Ther. 1977 Jun;21(6):736-43. doi: 10.1002/cpt1977216736.

Clinical pharmacokinetics of valproic acid.丙戊酸的临床药代动力学

Clin Pharmacokinet. 1980 Jan-Feb;5(1):67-83. doi: 10.2165/00003088-198005010-00002.

Disposition of sodium valproate in epileptic patients.丙戊酸钠在癫痫患者体内的处置情况。

Br J Clin Pharmacol. 1978 Jun;5(6):495-9. doi: 10.1111/j.1365-2125.1978.tb01663.x.

Clinical pharmacological aspects of valproate sodium.丙戊酸钠的临床药理学方面

Epilepsia. 1977 Jun;18(2):149-57. doi: 10.1111/j.1528-1157.1977.tb04463.x.

[On the enteral absorption of valproic acid (author's transl)].

Arzneimittelforschung. 1977;27(5):1088-90.

Disposition of valproic acid in man.丙戊酸在人体内的处置。

Eur J Clin Pharmacol. 1977 Oct 14;12(2):125-32. doi: 10.1007/BF00645133.

Pharmacokinetic studies with valproic acid in man.丙戊酸在人体中的药代动力学研究。

Arzneimittelforschung. 1977;27(5):1085-8.

Use of antiepileptic drugs in the presence of liver and kidney diseases: a review.肝肾疾病患者使用抗癫痫药物：综述

Epilepsia. 1982;23 Suppl 1:S65-79. doi: 10.1111/j.1528-1157.1982.tb06092.x.

Effects of aging and liver disease on disposition of lorazepam.

Clin Pharmacol Ther. 1978 Oct;24(4):411-9. doi: 10.1002/cpt1978244411.

引用本文的文献

Clinical Consequences of Disproportionate Free Valproate Elevation in Critically Ill Adult Patients: A Multicenter Retrospective Cohort Study.重症成年患者游离丙戊酸异常升高的临床后果：一项多中心回顾性队列研究

Neurocrit Care. 2025 Mar 25. doi: 10.1007/s12028-025-02243-y.

Estimation of apparent clearance of valproic acid in adult Saudi patients.估算成年沙特患者体内丙戊酸的表观清除率。

Int J Clin Pharm. 2019 Aug;41(4):1056-1061. doi: 10.1007/s11096-019-00864-w. Epub 2019 Jun 20.

Physiologically based pharmacokinetic modeling of disposition and drug-drug interactions for valproic acid and divalproex.基于生理学的丙戊酸和丙戊酸钠处置及药物相互作用的药代动力学模型。

Eur J Pharm Sci. 2018 Jan 1;111:465-481. doi: 10.1016/j.ejps.2017.10.009. Epub 2017 Oct 10.

Pharmacokinetic of antiepileptic drugs in patients with hepatic or renal impairment.肝或肾功能损害患者的抗癫痫药物药代动力学。

Clin Pharmacokinet. 2014 Jan;53(1):29-49. doi: 10.1007/s40262-013-0107-0.

Pharmacokinetic changes of psychotropic drugs in patients with liver disease: implications for dose adaptation.肝病患者精神药物的药代动力学变化：剂量调整的意义。

Drug Saf. 2009;32(7):561-78. doi: 10.2165/00002018-200932070-00003.

Drug administration in chronic liver disease.慢性肝病中的药物给药

Drug Saf. 1997 Jul;17(1):47-73. doi: 10.2165/00002018-199717010-00004.

Intra-dose variation in plasma protein binding of sodium valproate in epileptic patients.癫痫患者中丙戊酸钠血浆蛋白结合的剂量内变异

Br J Clin Pharmacol. 1982 Sep;14(3):399-404. doi: 10.1111/j.1365-2125.1982.tb01998.x.

Clinical pharmacokinetics of valproic acid.丙戊酸的临床药代动力学

Clin Pharmacokinet. 1980 Jan-Feb;5(1):67-83. doi: 10.2165/00003088-198005010-00002.

Free level monitoring of antiepileptic drugs. Clinical usefulness and case studies.抗癫痫药物的游离水平监测。临床实用性及病例研究。

Clin Pharmacokinet. 1984 Jan;9 Suppl 1:71-8. doi: 10.2165/00003088-198400091-00009.

Prediction of the disposition of nine weakly acidic and six weakly basic drugs in humans from pharmacokinetic parameters in rats.根据大鼠药代动力学参数预测九种弱酸性和六种弱碱性药物在人体内的处置情况。

J Pharmacokinet Biopharm. 1985 Oct;13(5):477-92. doi: 10.1007/BF01059331.

本文引用的文献

The use of indocyanine green in the measurement of hepatic blood flow and as a test of hepatic function.吲哚菁绿在肝血流测量及肝功能检测中的应用。

Clin Sci. 1961 Aug;21:43-57.

[Hepatoprotective and hepatoregenerative effects of di-n-propylacetic molecules].二正丙基乙酸分子的肝保护和肝再生作用

Therapie. 1967 May-Jun;22(3):631-9.

Blood levels of drug at the equilibrium state after multiple dosing.多次给药后达到平衡状态时药物的血药浓度。

Nature. 1965 Sep 18;207(5003):1301-2. doi: 10.1038/2071301a0.

Time integral of drug concentration in the central (plasma) compartment.中央（血浆）室药物浓度的时间积分。

J Pharm Sci. 1970 May;59(5):722-3. doi: 10.1002/jps.2600590537.

Metabolism of amylobarbitone in patients with chronic liver disease.慢性肝病患者中异戊巴比妥的代谢

Br J Pharmacol. 1972 Mar;44(3):549-60. doi: 10.1111/j.1476-5381.1972.tb07292.x.

Pharmacokinetics of glymidine (glycodiazine) and tolbutamide in acute and chronic liver diseases.格列嘧啶（甘氨二嗪）和甲苯磺丁脲在急慢性肝病中的药代动力学

Arzneimittelforschung. 1973 Dec;23(12):1801-7.

Clearance concepts in pharmacokinetics.药代动力学中的清除概念。

J Pharmacokinet Biopharm. 1973 Apr;1(2):123-36. doi: 10.1007/BF01059626.

The disposition of propranolol. 3. Decreased half-life and volume of distribution as a result of plasma binding in man, monkey, dog and rat.普萘洛尔的处置。3. 由于人、猴、狗和大鼠体内的血浆结合作用，半衰期和分布容积降低。

J Pharmacol Exp Ther. 1973 Jul;186(1):114-22.

Classification of cirrhosis.

Am J Gastroenterol. 1975 Dec;64(6):437-51.

Influence of acute viral hepatitis on phenytoin kinetics and protein binding.急性病毒性肝炎对苯妥英动力学及蛋白结合的影响。

Clin Pharmacol Ther. 1975 Jun;17(6):685-91. doi: 10.1002/cpt1975176685.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验